Delivery Order SPE2DB20D3103-SPE2DB24FL5K2
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The contract has a ceiling value of $1,567.32 and is a firm fixed-price delivery order with an ultimate completion date of April 20, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a $1,294.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4565218366 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, with a period of performance through July 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded several federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to provide a wide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,886.90, is for the supply of 4567495266 CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRJC1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.12 firm fixed-price delivery order contract covers the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, with a period of performance through May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,340.71, is for the delivery of CLOBAZAM 10 MG TABLET 100S, a medical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award, valued at $5,962.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of 4567254711 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,024.26 firm fixed price delivery order is for the supply of 4565123421 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,541.32, is for the delivery of 4566444918 CLOBAZAM 10 MG TABLET 100S. It is a Firm Fixed Price Delivery Order contract with a completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $7,233.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4567361463 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with a ceiling value of $1,238.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the supply of 4565405730 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as several...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL5K2Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,984.60, is for the supply of 4562816595 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. The contract has a ceiling value of $3,984.60 and a completion date of November 15, 2023. This is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/14/23 |